Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
VRCA.OQ - Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 03:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Well, good morning. Thanks so much for joining our forty-sixth annual healthcare conference. I'm Stacy Ku, one of the biotech analysts at TD Cowan, and I'm joined by my colleague Bish Shaw. We're very happy to be hosting the Berrica team with us today. We have Jason Riegger, CEO. In the crowd we have John Kriby, CFO.
So now having stepped into the YCAT relaunch for Molluscum Cadiziosum, now about a year ago, looking forward to hearing about the progress.
This is very loud. Apologize, guys.
Thank you.
So before we dig into maybe all the different nuances around the relatch and remind us what is the value proposition of Yanth and molluscum and what's the real big unmet

